喜炎平注射液治療老年社區(qū)獲得性肺炎（痰熱壅肺證）臨床療效觀察
發(fā)布時間：2018-10-13 18:30
【摘要】：目的:通過觀察喜炎平注射液治療老年社區(qū)獲得性肺炎(痰熱壅肺證)的臨床癥狀、體征、48h退熱情況、體溫恢復(fù)正常所需時間、外周血白細胞、超敏C反應(yīng)蛋白、降鈣素原、白介素-6及肺CT炎癥吸收的改善情況,評價喜炎平注射液治療老年社區(qū)獲得性肺炎(痰熱壅肺證)臨床療效。方法:收入2016年6月至2017年2月解放軍第463醫(yī)院呼吸科病房收治的老年社區(qū)獲得性肺炎(痰熱壅肺證)患者80例,采用隨機數(shù)字表法分為治療組(喜炎平+西醫(yī)常規(guī)治療)和對照組(西醫(yī)常規(guī)治療)。療程10天,10天后觀察治療組與對照組患者的主要癥狀(咳嗽、咳痰)、次要癥狀(發(fā)熱、口渴、大便)、體征(濕Up音)、48h退熱情況及體溫恢復(fù)正常所需時間,外周血白細胞計數(shù)(White blood cell,WBC)、超敏C反應(yīng)蛋白(High-sensitivity c-reactive protein,hs-CRP)、降鈣素原(Procalcitonin,PCT)及血清白介素-6(interleukin-6,IL-6)改善情況及臨床療效。結(jié)果:1.在臨床療效方面,治療組總有效率為92.5%,對照組總有效率為82.05%。治療組優(yōu)于對照組(P0.05)。2.在中醫(yī)證候評分及退熱時間方面,治療組治療后中醫(yī)證候評分、總積分(除口渴、大便外)、48h退熱情況及體溫恢復(fù)正常所需時間均較對照組改善明顯(P0.05)。3.在抗感染方面,兩組外周血WBC、hs-CRP、IL-6及肺部CT炎癥吸收情況,治療后組間比較治療組優(yōu)于對照組,有統(tǒng)計學(xué)差異(P0.05),PCT治療后組間比較無統(tǒng)計學(xué)差異(P0.05)。結(jié)論:1.西醫(yī)常規(guī)治療基礎(chǔ)上加用喜炎平注射液治療老年社區(qū)獲得性肺炎(痰熱壅肺證)的臨床療效顯著。2.西醫(yī)常規(guī)治療基礎(chǔ)上加用喜炎平注射液治療老年社區(qū)獲得性肺炎(痰熱壅肺證),在臨床癥狀(咳嗽、咳痰、發(fā)熱)、體征(濕Up音)、總積分及48h退熱情況及體溫恢復(fù)正常所需時間方面,均優(yōu)于西醫(yī)常規(guī)治療,利于疾病轉(zhuǎn)歸且能夠縮短患者退熱時間及發(fā)熱天數(shù)。3.西醫(yī)常規(guī)治療基礎(chǔ)上加用喜炎平注射液治療老年社區(qū)獲得性肺炎(痰熱壅肺證),能進一步改善外周血WBC、hs-CRP、IL-6,肺部CT炎癥吸收情況從而促進炎癥吸收。
[Abstract]:Objective: to observe the clinical symptoms, signs, 48 h antipyretic condition, the time required for body temperature recovery, peripheral white blood cells, hypersensitive C-reactive protein, procalcitonin in the treatment of senile community-acquired pneumonia with Xiyanping injection. To evaluate the clinical effect of Xiyanping injection in the treatment of senile community-acquired pneumonia (syndrome of phlegm-heat obstruction of lung). Methods: from June 2016 to February 2017, 80 elderly patients with community acquired pneumonia (syndrome of phlegm and heat obstructing the lung) were admitted to the respiratory ward of the 463 Hospital of PLA. The patients were randomly divided into two groups: treatment group (routine treatment of Xiyanping western medicine) and control group (routine treatment of western medicine). After 10 days of treatment, the main symptoms (cough, expectoration), secondary symptoms (fever, thirst, stool), physical signs (wet Up sound), 48 h antipyretic condition and the time needed for body temperature to return to normal were observed in the treatment group and the control group. Peripheral blood leukocyte count (White blood cell,WBC), hypersensitive C-reactive protein (High-sensitivity c-reactive protein,hs-CRP), procalcitonin (Procalcitonin,PCT) and serum interleukin-6 (interleukin-6,IL-6) were improved and their clinical efficacy was evaluated. The result is 1: 1. The total effective rate was 92.5 in the treatment group and 82.05 in the control group. The treatment group was superior to the control group (P0.05). In TCM syndrome score and antipyretic time, the treatment group after treatment TCM syndrome score, total score (except thirst, stool), 48h antipyretic condition and temperature recovery time were significantly improved compared with the control group (P0.05). In the aspect of anti-infection, the inflammatory absorption of WBC,hs-CRP,IL-6 in peripheral blood and lung CT in the two groups was better than that in the control group after treatment. There was no statistical difference between the two groups (P0.05) after), PCT treatment (P0.05). Conclusion: 1. On the basis of routine treatment of western medicine plus Xiyanping injection in the treatment of elderly community acquired pneumonia (phlegm heat obstruction lung syndrome) the clinical efficacy is significant. 2. On the basis of routine treatment of western medicine, combined with Xiyanping injection to treat elderly community-acquired pneumonia (phlegm-heat obstruction of lung syndrome), in clinical symptoms (cough, expectoration, phlegm), Fever), physical sign (wet Up sound), total score, 48 h antipyretic condition and the time needed for body temperature to return to normal were better than that of western medicine routine treatment, which was beneficial to the outcome of the disease and could shorten the time of fever and the days of fever. On the basis of routine treatment of western medicine, the treatment of elderly community-acquired pneumonia (phlegm-heat obstruction of lung syndrome) with Xiyanping injection can further improve the inflammatory absorption of peripheral blood WBC,hs-CRP,IL-6, lung CT and thus promote inflammatory absorption.
【學(xué)位授予單位】：遼寧中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R563.1
本文編號：2269544
[Abstract]:Objective: to observe the clinical symptoms, signs, 48 h antipyretic condition, the time required for body temperature recovery, peripheral white blood cells, hypersensitive C-reactive protein, procalcitonin in the treatment of senile community-acquired pneumonia with Xiyanping injection. To evaluate the clinical effect of Xiyanping injection in the treatment of senile community-acquired pneumonia (syndrome of phlegm-heat obstruction of lung). Methods: from June 2016 to February 2017, 80 elderly patients with community acquired pneumonia (syndrome of phlegm and heat obstructing the lung) were admitted to the respiratory ward of the 463 Hospital of PLA. The patients were randomly divided into two groups: treatment group (routine treatment of Xiyanping western medicine) and control group (routine treatment of western medicine). After 10 days of treatment, the main symptoms (cough, expectoration), secondary symptoms (fever, thirst, stool), physical signs (wet Up sound), 48 h antipyretic condition and the time needed for body temperature to return to normal were observed in the treatment group and the control group. Peripheral blood leukocyte count (White blood cell,WBC), hypersensitive C-reactive protein (High-sensitivity c-reactive protein,hs-CRP), procalcitonin (Procalcitonin,PCT) and serum interleukin-6 (interleukin-6,IL-6) were improved and their clinical efficacy was evaluated. The result is 1: 1. The total effective rate was 92.5 in the treatment group and 82.05 in the control group. The treatment group was superior to the control group (P0.05). In TCM syndrome score and antipyretic time, the treatment group after treatment TCM syndrome score, total score (except thirst, stool), 48h antipyretic condition and temperature recovery time were significantly improved compared with the control group (P0.05). In the aspect of anti-infection, the inflammatory absorption of WBC,hs-CRP,IL-6 in peripheral blood and lung CT in the two groups was better than that in the control group after treatment. There was no statistical difference between the two groups (P0.05) after), PCT treatment (P0.05). Conclusion: 1. On the basis of routine treatment of western medicine plus Xiyanping injection in the treatment of elderly community acquired pneumonia (phlegm heat obstruction lung syndrome) the clinical efficacy is significant. 2. On the basis of routine treatment of western medicine, combined with Xiyanping injection to treat elderly community-acquired pneumonia (phlegm-heat obstruction of lung syndrome), in clinical symptoms (cough, expectoration, phlegm), Fever), physical sign (wet Up sound), total score, 48 h antipyretic condition and the time needed for body temperature to return to normal were better than that of western medicine routine treatment, which was beneficial to the outcome of the disease and could shorten the time of fever and the days of fever. On the basis of routine treatment of western medicine, the treatment of elderly community-acquired pneumonia (phlegm-heat obstruction of lung syndrome) with Xiyanping injection can further improve the inflammatory absorption of peripheral blood WBC,hs-CRP,IL-6, lung CT and thus promote inflammatory absorption.
【學(xué)位授予單位】：遼寧中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R563.1
【參考文獻】
相關(guān)期刊論文 前10條
1 朱剛;鐘平;劉彬;馬爭飛;蘇永興;;PCT、Hs-CRP和AIS-APS對SAP風(fēng)險評估的價值[J];臨床肺科雜志;2017年01期
2 蘇慶珠;孫興華;楊艷華;王雪飛;李虹霖;;中西醫(yī)結(jié)合治療社區(qū)獲得性肺炎痰熱壅肺證臨床研究[J];中醫(yī)學(xué)報;2016年12期
3 鐘云青;許光蘭;王秀峰;楊樹棟;翁惠;;加味陳平湯治療老年社區(qū)獲得性肺炎患者痰濕阻肺夾瘀證的臨床觀察[J];中國實驗方劑學(xué)雜志;2017年05期
4 田玉恒;鄭有光;王彤兵;陳書文;馬原;;莫西沙星聯(lián)合喜炎平對社區(qū)獲得性肺炎老年患者血清炎癥因子水平及T淋巴細胞亞群的影響[J];中華醫(yī)院感染學(xué)雜志;2016年15期
5 吳濤;任朝鳳;;血必凈聯(lián)合抗生素治療老年重癥社區(qū)獲得性肺炎療效分析[J];大家健康(學(xué)術(shù)版);2016年13期
6 董玉梅;靳桂明;吳穎濤;張帆;曹軍皓;;降鈣素原對患者醫(yī)院感染的診斷與預(yù)后的價值研究[J];中華醫(yī)院感染學(xué)雜志;2016年03期
7 甘大文;;穴位敷貼聯(lián)合西藥治療老年性肺炎的療效觀察[J];保健醫(yī)學(xué)研究與實踐;2015年03期
8 梁少紅;田峰;馮曙平;冼慧儀;吳凡;;喜炎平聯(lián)合胸腺五肽治療老年性病毒性肺炎的臨床療效及費效比分析[J];中國醫(yī)藥指南;2015年16期
9 鄭金菊;張少強;;PCT與CRP及白細胞計數(shù)對細菌感染性疾病診斷價值[J];青島大學(xué)醫(yī)學(xué)院學(xué)報;2015年02期
10 范漢成;;美洛西林鈉舒巴坦鈉聯(lián)合喜炎平治療中老年社區(qū)獲得性肺炎療效觀察[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2014年23期
，本文編號：2269544
本文鏈接：http://sikaile.net/yixuelunwen/huxijib/2269544.html
最近更新
教材專著
